The New York State Department of Health has updated its statewide standing order, allowing pharmacists to administer the respiratory syncytial virus (RSV) vaccine to eligible individuals across New York. The new directive is aimed at increasing access to the vaccine for older adults and pregnant people.
“Respiratory syncytial virus (RSV) is a common illness we see each fall and winter, and while many experience only mild, cold-like symptoms, it can be serious, especially for older adults and infants,” said State Health Commissioner Dr. James McDonald. “This updated standing order now makes it easier for eligible New Yorkers to protect themselves and their loved one.”
Data from the Centers for Disease Control and Prevention indicates that RSV causes between 60,000-160,000 hospitalizations annually in the United States among adults aged 65 years and older. Deaths in this age group range from 6,000 to 10,000 per year.
The Department of Health recommends a one-time RSV vaccination for adults aged 50 years or older. This group faces higher risks due to weakened immune systems associated with aging as well as chronic health conditions such as heart, lung, kidney, or liver disease. Adults residing in long-term care facilities are also encouraged to receive the vaccine.
Adults who are uncertain about their risk factors should consult healthcare providers for guidance on whether vaccination is appropriate.
The department notes that all adults aged 75 years and older face increased risks of severe complications from RSV infection and are advised to get vaccinated with one of the approved vaccines—mRESVIA, Arexvy or Abrysvo.
Infants under six months old can be protected if a pregnant person receives a single dose of Abrysvo during weeks 32 through 36 of pregnancy within RSV season. Alternatively, infants may receive preventive antibody treatments such as nirsevimab or clesrovimab after birth; typically only one method is necessary per infant.
For those infants who contract RSV despite these measures, treatment may involve supportive care like hydration or oxygen therapy. Severe cases could require hospitalization.
Healthcare providers serving pregnant people are encouraged to inform patients about both maternal vaccines and infant monoclonal antibody products so that patient preferences can help guide decisions regarding prevention strategies.
RSV is highly contagious and can lead to serious outcomes like pneumonia or bronchiolitis in adults—particularly those with pre-existing lung disease—as well as severe illness in infants.
The Department continues to recommend general precautions against respiratory viruses.
